Convalescent Plasma in COVID

CEimpact Podcast

Respiratory failure from COVID-19 should be treated as soon as possible. Join host, Geoff Wall, as he evaluates the the role of convalescent plasma in treating patients with COVID-19 and on mechanical ventilation.
The GameChanger
COVID-19 is still a significant concern acutely and for long-term complications. Convalescent plasma may benefit severely ill COVID-19 patients on mechanical ventilation and with acute respiratory distress syndrome (ARDS).
Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
Reference
Misset B, Piagnerelli M, Hoste E, Dardenne N, Grimaldi D, Michaux I, De Waele E, Dumoulin A, Jorens PG, van der Hauwaert E, Vallot F, Lamote S, Swinnen W, De Schryver N, Fraipont V, de Mey N, Dauby N, Layios N, Mesland JB, Meyfroidt G, Moutschen M, Compernolle V, Gothot A, Desmecht D, Taveira da Silva Pereira MI, Garigliany M, Najdovski T, Bertrand A, Donneau AF, Laterre PF. Convalescent Plasma for Covid-19-Induced ARDS in Mechanically Ventilated Patients. N Engl J Med. 2023 Oct 26;389(17):1590-1600. doi: 10.1056/NEJMoa2209502. Epub 2023 Oct 25. PMID: 37889107.
https://www.nejm.org/doi/full/10.1056/NEJMoa2209502?query=featured_home

Pharmacist Members, REDEEM YOUR CPE HERE!

Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)
CPE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the latest NIH treatment guidelines for COVID-19 patients who are hospitalized
2. Describe the use of convalescent plasma in the context of a COVID-19 treatment algorithm
0.05 CEU/0.5 Hr
UAN: 0107-0000-23-354-H01-P
Initial release date: 11/20/2023
Expiration date: 11/20/2024
Additional CPE details can be found here.
Follow CEimpact on Social Media:
LinkedIn
Instagram